Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum
In Brief: Antman, Chabner Vie For ASCO President-Elect; Irwin Krakoff Is 1993 Karnofsky Lecturer
Frank Rauscher, 62, Former NCI director, Dead Of Heart Attack
HHS: Gallo Committed Scientific Misconduct In AIDS Virus Discovery
IOM To Advise Army On Spending $210 Mil. Breast Cancer Money
Six Panels To Help NCI Identify Progress; NCINews Roundup
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
